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Wc studied the role of non.selecttv© tyi~ (ET.) of ¢ndothelin (ET} receptor in the vaseulature, using a ligand specific to the fiT. receptor) [Olu~] •
sarafotoxin S6b ([Olu'*lgR'rh}. Endothelium.containln8 rat thoracic aorta pos~s~d specific binding sites For ~)l.[OhP]SRTb. which were almost 
diminatcd by removal ctf the endothelium, while ET.3-sl~cific binding sites were not detected in tl' c endothdium.intaet rat aorl=. Only ET, receptor 
was deIected in the membranes From the endothdium of porcine thoracic aorta. [GIu'~ISR.Tb exerted only vasodilalion in rat aortic rinB. These 
findings indicate that El?. receptors are located on vascular endothellum and linked to vasodilation. 
~ldothelin; Sarafotoxin; Endothclitlm: Endothelial cell; Receptor; Vasodilation 
1. INTRODUCTION 
Endothelins (ETs) belong to a potent vasoactive pep- 
tide family consisting of three isopeptides, ETA) ET-2 
and ET-3 [1]. Sarafotoxins (SRTs), having chemical 
structures imilar to those of ETs, also consist of a 
novel cardiotoxic peptide family [2] and these peptides 
interact witla ET receptors [1]. A diverse set of phar- 
macological activities with different potencies exerted 
by ET/SRT family peptides [3-6] suggested the ex- 
istence of ET/SRT receptor subtypes. We have 
reported that two distinct subclasses of ET receptors, 
namely, ET-l-specific and ET /SRT family-common 
receptors, are distributed in various proportions in 
human and porcine tissues [7]. Most recently, the struc- 
tures of the two ET receptor subtypes have been deter- 
mined by cloning cDNAs encoding those subtypes [8,9], 
and it was recommended that the ET-1 specific type be 
called ETA and the non-selective one ETn [10]. 
There have been accumulating observations ug- 
gesting that ET.l-secreting endothelial ceils (ECs) 
themselves elicit ET-dependent vasodilation by releas- 
ing the endothelium-derived r laxing factor (EDRF) or 
prostacyclin (PGI2) [4,11]. However, the precise 
mechanism is still ambiguous. Although it has been 
reported that the three ETs are almost equipotent in 
producing transient vasodilation [3,4], it was also 
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reported that only an ET-3-specific receptor, which has 
no affinity for ET-I, is located on cultured bovine ECs 
[121. 
The present study was designed to clarify the inter- 
relationships between the ET receptor subtypes and the 
biological responses in the vasculature using an ETa 
receptor-specific agonist, [Glug]SRTb. 
2. MATERIALS AND METHODS 
2,1, Materials 
Synthetic ET-I, ET-2 and ET.3 were purchased from Peptide in- 
stitute (Osaka, Japan), Sarafotoxin S6b(SRTb), sarafoto~in $6c 
(SRTc) and [GluglSRTb were synthesized by solid.phase method and 
the quality of the structures was verified by reverse-phase HPLC, 
amino acid analyses and FAB mass spectroscopy. Male Sprague- 
Dawley rats (300-350 g) were obtained from Charles River, Japan. 
2.2, Binding assays 
The microsomal fractions were prepared from porcine and rat 
thoracic aortas as previously described [13l, The endothelia of the 
aortas were removed mechanically by gentle scraping of the luminal 
surface with a small glass plate. Monoiodinated ET-I (t2Si-ET-I), 
ET-3 (tz'~I-ET-3)and [GluglSRTb (12sI-[Glug]SRTb) were prepared by 
means of HPLC performed in essentially the same manner as 
previously described [7]. Each radioligand has a specific activiw of 
2.10-2,15 #Ci/pmol. Binding studies were performed and the results 
were analyzed by a computer program for nonlinear curve-fitting as 
described [7], Briefly, the membranes (0.1-0,3 rag) were incubated 
with 100 pM each of iodinated ligands for 90 rain at 25°C in 0.5 ml 
of 50 mM Hopes buffer (pH 7,4) containing 0,15 M NaCI, 5 mM 
MgCI2, 0.4 mM phenylmethylsulfonyl fluoride. 1 mg/ml of bovine 
serum albumin and 0.5 mg/ml of bacitracin, Bound radioligand was 
determined by trapping on Whatman GF/B filters. Nonspecific bin. 
ding was determined using 1,0 p.M each of the nonradioactive ligands 
and the values were 5-25°70 of the total binding. 
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2.,!, k'tt~ot~n~trk'lor ~tnd v~t~tlll~lor ttCliv#t¢~ i rl#; ao¢lt¢ tl'~lrlt,~t 
Th~ ¢ndolheligm,denuded rat ~orll¢ tlnl!~ wer¢ uTtognl~d in ILl ml 
orllan baflt Riled with Kreh~=Hemeleit sohtlio~. ~lnd ~omr;~gtion war 
mea~gred i~omelrteally gtl~l~ a forw di~pla,~em~m ttan~d.¢er a~ 
prevloudy de~¢ribcd Pl, The te~llnll en~lo.,,~ a.t ! .Oil. The¢on~¢nera. 
Ilon/re~pon~e reladon~htp~ for IQu~'JSRTb • and Wr, l.l~d,,ced 
va~o¢on~lrb:tion were ¢Npcrmtned by means of ettmulaflv¢ adminhlra= 
lion~, Th~ ¢onlra~tlle ~espon~e Io the~e ~pttde~ wa~ e~pre~¢d a~ ~t 
pereemalle or thai elicited by 40 mM KC! which wt;s l~tken a~ 100%, 
V¢~odllalor esoonse~ zo there peplide~; were reeortled uiinlll et}. 
dothelium/inl~cl aorta pr~p~f~tl|o~ pre~:on~lri¢;~d with I0 =? M 
phenylephrtfle, and were expressed a~ per~:enta=~s or tlw va.~odilation 
induced by 10" ~ M papaverlne in ea~l~ prepar~tlilon. 
3. RESULTS 
3.1. Specific binding sites fo r  ~'~I.ET-I and 
~I . [Glu~]SRTb ia rat and porcin~ aortas 
[GIu~]SRTb displaced the bound ~a~I-ET-I with a 
potency comparable to that of  ET-! in rat cerebral 
membranes (Fig. IA), which contain mainly ETa recep- 
tor, whereas in the ~ortic membranes, which contain 
mainly ETA receptor, the displacability of [Glu~]SRTb 
was only slight even at l0 "~ M (Fig, iB), Specific and 
saturable bindings were observed not only for ~'~I-ET-I 
but also for ~z~I-[Glu~lSRTb in the membranes 
prepared from endothelia-containing aortas of  rat (Fig. 
2, solid line), The Scatchard analyses displayed a single 
component of  high affinity binding sites for both 
ligands, and the apparent dissociation constant (K~) 
values were 90 and 380 pM for nz~I-ET-I and =Z~l- 
[Glu°]SRTb, respectively, The maximal binding capaci- 
ty (Bm,,) for tZSl-[Glu~]SRTb was approximately 5070 of 
that for ~zSI-ET-1. ET and SRT isopeptides were almost 
equipotent in displacing ~:~I-[GIug]SRTb from the bin- 
ding sites in the aortic membranes (Fig. 3A). Similarly, 
~2~I-ET-3 specifically bound to the endothelium- 
contaimng aorta and was displaced completely and 
equipotently by ET/SRT isopeptides including 
[GIu~]SRTb (Fig. 3B). The Bmax value for t25I- 
[Glu°]SRTb in the aorta was markedly reduced by 
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Fig, 1. Competitive binding of ~abI-ET-I to the membranes (0.1 mg) 
obtained from rat cerebral cortex (A) and thoracic aorta (B) by 
[GIu~]SRTb (070), ET-1 (o), ET-2 ( .x ), ET-3 ( r~ ), SRTb ( • ) and SRTc 
(B), The maximal ~a~I-ET-I bindings for the controls were 260 and 
290 fmol/mg protein for cerebral nd aortic membranes, respectively, 
~¢rapin= of f  the endo|helium bu| the #,~,  for i :~i.ET-I  
wa~ not afro:ted (Filj, 2, dotted line). A ~inille ¢ la~ or 
hi=h aff inity bindin$ sites for I;LSI-ET-I (K~ ~ 40= 11 
pM, B. , , ,  - 175 ± 33 fmoltmtt protein, mean ¢ S .E .M. .  
n m 3} was detected in the membranes prepared from. the 
intima (endothelium) of  porcine aorta and tile bound 
t=~I.ET.I was non-~elecfiveiy displaced by ETtSRT 
isopeptidcs (Fig. 4A). while ~=~I-ET-I boLlnd to the 
membranes obtaine(L from the media (smooth muscle) 
was displayed sensitively by ET-I and ET.2 but nol by 
[Glu~]SRTb even at l0 ~ ~ M (Fill, 4B). Specific binding 
sites for ==~I-[Ghi~]SRTb and t=Sl-ET-3 were also 
detected in the intima membranes, and those were 
displaced eqLlipotently by each of  tl~e ET/SRT isopep- 
tides (data not sl~own), 
3.2. Effects of  [Glug]SR Tb and £T. I  on rat aortic rings 
In the endothelium-denuded rat aorta preparations, 
ET- I  caused slowly developing and concentration- 
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Fig, 2, Saturation bindings o f  J251-ET-I to, v )  (A) and ~251- 
[Glug]SRTb (a , . )  (B) to the membranes obtained from en- 
dothel ia/ intact (solid line) and endothel ia/denuded Idotted line) aor- 
tas of  rat, and the Scatehard analyses, Binding data were obtained 
from one experiment which is representative o f four independent ex. 
penments ,  and are plotted after correction for nonspccific bindings, 
The amounts  of membranes  used were 0. Img and 0.3 mg for '2Sl- 
ET-I and ~zsI.[Glug]SRTb, respecti~.ely, The respective B,,,.x values 
for l:bl-ET-I and 1251-[Glug]SRTb were 942 ± 49 and 45 ± 8 
fmo l /mg protein for the endothelium-intaet aorta, and 930 -~ .52 and 
4 ::: 1' fmo l /mg protein for the endothel ium-denuded aorta 
( *P< 0.01 vs B,~.L~ for t2Sl-[GIug]SRTb in intact aorta), The respective 
K,i values for 12Sl.ET.l and 1251-[GIug]SRTb were 86 ± 16 and 375 ± 
43 pM for the endothel ium/intact  aorta, and 104 _+ 18 and 340 ± 36 
pM for the endothel ium-denuded aorta (mean ± S,E,M,, n =4),  
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FiB. 3. Competitive bindinss or ttJl.[Qlu~]SRTb (A] and tZ~l-ET.3 (B) to the membranes (0.3 ms} obtained from ~ndothellum/inutcl aorta of rat 
by [GIu~ISRTb to), ET. I (*~), ET.2 ( a }, ET.3 t o ) ~md SRTc ( i ), Each l~oint is the m~a~ or lhr¢~c exp~rlrncnls, Th~ m~x[mal blndings For the con- 
trois were I I and 16 rmol/mB protein for u~i,[GIt~]SRl'b anti ~"~I,ET.3. resp~ctis'el)~. TI1¢ B,,,, trod K,~ values for ET.3 wcrc ~;2 rmoltm8 protein 
anti 90 pM, respectively, 
dependent vasoconstriction at concentrations ranging 
from l0 "tl i to 10 *~ M, but [Glu'J]SRTb caused no 
vasoconstriction even at 10- ~ M (Fig. 5A). By contrast, 
[Glu~]SRTb produced a transient and concentration- 
dependent vasodilation at concentrations ranging from 
i0"aM to 3 x 10 -~ M in the endothelium/intact orta 
preparations which were preconstricted with 
phenylephrine (10 "7 M), but ET-I produced no 
vasodilation; instead, a potent vasoconstriction was in- 
duced (Figs. 5B and 6). The vasodilator esponse to 
[GIug]SRTb was completely eliminated by removal of 
the endothelium or by prctreatment with methylene 
blue (10 "s M), an inhibitor for soluble guanylate 
cyclase, for 30 rain even in the endothelium/intact orta 
preparations (Fig. 6), 
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Fig, 4. Competit ive binding of  t2~I-ET-I to the membranes (0,1 rag) 
obtained from the intima (A) and tlae media (B) of porcine thoracic 
aorta by [GluglSRTb (®), ET-I (o), ET-2 (a )  and ET-3 ( [] ). Each 
point is the mean of three experiments, The maximal binding for the 
controls were 115 and 150 fmol /mg protein for the intima and the 
media, respectively. The Bmax and Ka values for ET-I in the media 
were 430 -,- 55 fmol/mg protein and 130 ~: 40 pM, respectively (mean 
-1- S,E.M., n = 3). 
4. DISCUSSION 
The present study provided direct evidence that 
ET/SRT family.common receptors (ETa) are located 
on vascular endothelium and are linked to vasodilation, 
and that ET-l-specific receptors (ET^)  on smooth mus- 
cle are linked to vasoconstriction. 
SRT.c, which has the substitution of Glu 9 in a cluster 
of charged residues (AspS-Lys~-Glut°) common to the 
other ET/SRT family [1,2], has virtually no affinity f'or 
ETA receptor [7], suggesting that Glu 9 may reduce the 
affinity of ET/SRT isopeptide for the ETA receptor. In- 
deed, the synthetic radiolabelable igand, [GluO]SRTb 
showed no affinity for the ETA receptor but retained a
full binding capability to the ETt) receptor. R&t thoracic 
aorta contained a significant amount of t2sI- 
[Glug]SRTb binding sites, namely, ETB receptor, but 
contained no ET-3-specific receptor (Fig. 3). The bin- 
ding sites for t2sI-[Glug]SRTb were almost eliminated 
by the removal of the endothelium from the aorta. 
Moreover, the membranes prepared from the porcine 
aortic endothelia possessed ETB receptor, which was 
not due to contamination f the smooth muscle mem- 
branes, because the media of aorta had only ETA recep- 
tor (Fig. 4). These observations clearly indicated that 
ETA and ETB receptors are localized on the media and 
the intima, respectively, in the vasculature. In contrast 
to the present study, Emori et al. have reported that 
cultured bovine ECS possess only ET-3-specific recep- 
tors [12]. However, their observation might be at- 
tributed to down-regulation f ETB receptors by self- 
secreted ET-1 and by the aging process, because it has 
been shown that the incubation of ECs with anti-ET-1 
serum significantly enhanced ET-l-induced increase in 
the intracellular Ca 2. level of ECs [14], and that ETB 
receptors detected in cultured ECs were converted to 
ET-3-preferring ones with aging [15]. 
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Fig, 6, A typical recording showing the effects of [Glug]SRTb and 
ET-I in rat aorta preparations preconstricted with phenylephrine as
well as the influences of removal of the endothelium and pretreatment 
with Methylene blue, [Glug]SRTb, [Glug]SRTb 3x 10 "~ M; ET-1, 
ET-I 3 x I0" 7 M) MB, Methylene blue 10" ~ M; PE° phcnylephrine 
10 "7 M; Pap, papaverine 10 -4 M. 
[Glug[SRTb,  which is thus considered to b ind ex- 
c lusively ETB receptor  in the vasculature,  exerted on ly  
vasod i la t ion ,  p robab ly  th rough the release o f  EDRF 
f rom the endothe l ium.  A poss ib le  exp lanat ion  of  the 
fact that  ET-1 d id  not  induce d i lat ion in the 
preconst r ic ted  aort ic  r ings might  be that ,  since ET- I  
had access to smooth  musc le  f rom both  the luminal  and  
advent i t ia l  sides o f  the aor ta ,  its constr ict ive effect 
overwhe lmed its d i la tor  ef fect .  In fact,  ET-1 injected in- 
to  the lumen of  iso lated rat  mesenter ie  artery exerted a 
t rans ient  vasod i la t ion  comparab le  to that  o f  
[GIug]SRTb (unpubl i shed ata) .  Hence,  the ET  fami ly -  
common receptor  is d i f fe rent ia ted  funct ional ly  for 
vasod i la t ion  in the vascu lature ,  whi le it has been sug- 
~ested that the common receptor is l inked to co,~stric- 
t ion in the broncl~us and the smal l  intest ine [16]. 
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